Regulatory Announcements
Scheme Effective
13 July 2010
Court Sanction of Scheme of Arrangement
8 July 2010
Holding(s) in Company
24 June 2010
Result of AGM
21 June 2010
Results of Shareholder Meetings
21 June 2010
Holding(s) in Company
18 June 2010
Holding(s) in Company
17 June 2010
Holding(s) in Company
14 June 2010
Posting of Scheme Document
28 May 2010
Holding(s) in Company
27 May 2010
Additional Listing and Directors Dealing
19 May 2010
Holding(s) in Company
19 May 2010
Holding(s) in Company
18 May 2010
Recommended all Cash Offer for FGN Plc.
13 May 2010
Final Results 2009
13 May 2010
Response to Share Price Movement
23 February 2010
Holding(s) in Company
16 February 2010
License Agreement with BioCentury Transgene (China)
25 January 2010
Additional Japanese Patent Granted
5 January 2010
Holding(s) in Company
17 December 2009
Chinese Patent Granted
16 December 2009
Holding(s) in Company
15 December 2009
License Agreement with Bayer Crop Science
3 December 2009
Placing to raise 3 million pounds sterling
1 December 2009
Poplar Development Agreement
23 November 2009
Holding(s) in Company
12 October 2009
Interim Results, 2009
29 September 2009
Agreement with Chinese Forest Academy
9 September 2009
FuturaGene Plc Annonces AGM Result
31 July 2009
FGN expands contract with RITF to disease solutions
13 July 2009
Director's shareholding
9 July 2009
Directors' shareholding and issue of equity
9 July 2009
Directorate Change
2 July 2009
FuturaGene Final Results 2008
30 June 2009
FuturaGene's CBD technologies to co-sponsor and present at Tree Biotechnology Conference
15 June 2009
FuturaGene and Targeted Growth to begin Field Trials
21 May 2009
FuturaGene to collaborate with Oregon State University
11 May 2009
Issue of Equity
5 May 2009
Holding(s) in Company
20 April 2009
Director's Shareholding
11 March 2009
Holdings In Company - 10:43
29 January 2009
Settlement of Litigation
31 December 2008
Holdings In Company - 11:13
24 December 2008
Holdings In Company - 14:40
23 December 2008
Holdings In Company - 14:37
23 December 2008
Share Price Movement
23 December 2008
Interim results for the six months ended 30 June 2008
30 September 2008
Share Price Movement
16 September 2008
AGM Result
11 August 2008
Rescheduling of AGM
17 July 2008
Rescheduling of AGM
14 July 2008
Additional Listing
03 June 2008
Holdings In Company
26 June 2008
Final Results
20 June 2008
Evogene and FuturaGene’s Wholly Owned Subsidiary, CBD Technologies, Ltd.
Collaborate to Improve Cotton Fiber Properties
15 April 2008
FuturaGene’s Wholly Owned Subsidiary, CBD Technologies, Ltd. (FGN’s CBD Tech) and Targeted Growth, Inc. (TGI) Announce Licensing Agreement for the Development of Crop Plants With Superior Agronomic Characteristics
2 April 2008
Additional Legal Proceedings
29 February 2008
Holdings In Company
18 February 2008
FuturaGene Legal Proceedings
5 February 2008
FuturaGene Announces Clarification to December 4, 2007 Press Release
19 December 2007
FuturaGene plc Legal Proceedings
4 December 2007
FuturaGene's Wholly Owned Subsidiaries, CBD Technologies, Ltd. and FuturaGene Consulting (Beijing) to Collaborate with The Chinese Academy of Forestry
24 October 2007
FuturaGene Announces Changes to its Scientific Advisory Panel
07 September 2007
FuturaGene Announces Appointment of Dr. Stanley Hirsch as Group Chief Executive Officer as well as Resignation of Mr. Kannan S. Grant
17 August 2007
FuturaGene announces collaboration between its CBD Technologies and Forage Genetics International on development of alfalfa with enhanced digestibility
1 August 2007
Annual Report 2006
2 July 2007
FuturaGene announces the details of its issued share capital and voting rights
27 December 2006
FuturaGene Acquires CBD Technologies
20 December 2006
Grant of Options to Directors 
28 November 2006
FuturaGene Announces the Acquisition of CBD Technologies
24 November 2006
FuturaGene Announces AGM Result
19 July 2006
Directorate Change
27 June 2006
FuturaGene Announces Appointment of New Board Member
26 June 2006
FuturaGene Granted 10-Year Business Licence in China
21 January 2006
Directorate Change
18 January 2006
Clarification RE Change of Adviser
03 October 2005
FuturaGene Announces The Appointment of Kannan Grant as Executive Director with Responsibility for Licensing Joint Ventures
06 July 2005
FuturaGene Licence for Osmotin Offers Possible Breakthrough Treatments For Obesity, Heart Disease and Diabetes
09 May 2005
FuturaGene Plans Chinese Joint Venture
29 March 2005
FuturaGene Announces The Appointment of David Malsbary As Non-Executive Director
05 January 2005
FuturaGene Announces The Appointment of Kannan Grant as Non-Executive Director
22 September 2004
OverNet Data PLC Announces Approval of Acquisition and Name Change
14 June 2004